Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the...
Saved in:
Published in | EMBO molecular medicine Vol. 9; no. 6; pp. 733 - 736 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.06.2017
John Wiley & Sons, Inc EMBO Press John Wiley and Sons Inc Springer Nature |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Reprogramming adult, fully differentiated cells to pluripotency
in vivo
via
Oct3/4
,
Sox2
,
Klf4
and
c‐Myc
(OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression
in vivo
that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that
in vivo
OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of
in vivo
reprogramming in regenerative medicine.
Graphical Abstract
de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term
in vivo
OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas. |
---|---|
AbstractList | Reprogramming adult, fully differentiated cells to pluripotency
in vivo
via
Oct3/4
,
Sox2
,
Klf4
and
c‐Myc
(
OSKM
) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term
OSKM
expression
in vivo
that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that
in vivo
OSKM
induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of
in vivo
reprogramming in regenerative medicine. Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. Reprogramming adult, fully differentiated cells to pluripotency via , , and (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa-Belmonte laboratory described a cyclic regime for short-term OSKM expression that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of reprogramming in regenerative medicine. Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c-Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa-Belmonte laboratory described a cyclic regime for short-term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. Graphical Abstract de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term in vivo OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas. Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term in vivo OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas. |
Audience | Academic |
Author | Kostarelos, Kostas de Lázaro, Irene Cossu, Giulio |
AuthorAffiliation | 1 Nanomedicine Lab Faculty of Biology, Medicine and Health The University of Manchester Manchester UK 2 Division of Cell Matrix Biology & Regenerative Medicine Faculty of Biology, Medicine and Health The University of Manchester Manchester UK |
AuthorAffiliation_xml | – name: 1 Nanomedicine Lab Faculty of Biology, Medicine and Health The University of Manchester Manchester UK – name: 2 Division of Cell Matrix Biology & Regenerative Medicine Faculty of Biology, Medicine and Health The University of Manchester Manchester UK |
Author_xml | – sequence: 1 givenname: Irene surname: de Lázaro fullname: de Lázaro, Irene organization: Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester – sequence: 2 givenname: Giulio orcidid: 0000-0001-5863-9593 surname: Cossu fullname: Cossu, Giulio organization: Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester – sequence: 3 givenname: Kostas orcidid: 0000-0002-2224-6672 surname: Kostarelos fullname: Kostarelos, Kostas organization: Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28455313$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1uEzEUhUeoiP7Amh0aiQ0sktoe_8ywQKqqAhWNuqCsLY_nenCYsYM9Scnb8Cw8GU6mhEQCIS9s2ed8vtc-p9mR8w6y7DlGU8wII-fQ9_2UICyQ4Aw9yk6wYGJCeUmPdmvBj7PTGOcIccZx-SQ7JiVlrMDFSRbvgnLRghvyYbPSwS4G611ulB58yF_dfvo4e53D90WAGDcHNuZfYZ0P_l6FJua6s85q1Y32Tm3N3uTW_fyxsiufa-i6PMAi-DaovreufZo9NqqL8OxhPss-v7u6u_wwubl9f315cTPRnHI04aKmhhCAsgLWlA3XoFNfosLYcABNENGgtCaa1KhEqMDMFBUoQUiJm7opzrLrkdt4NZeLYHsV1tIrK7cbPrRShcHqDqRhUABhSot0N9CiKnRjaqNKxEoohEistyNrsax7aHR6sKC6A-jhibNfZOtXklFGEOUJ8PIBEPy3JcRBzv0yuNS_xBWiSFBC8R9Vq1JV1hmfYLq3UcuL9MGC0IrRpJr-RZVGA73VKSHGpv0Dw_lo0MHHGMDsCsdIboMkN0GSuyAlx4v9fnf638lJgjej4D7dtf4fT17NZrN9OhrNMflcC2HvMf5R0C80HOlw |
CitedBy_id | crossref_primary_10_1007_s12035_018_0888_0 crossref_primary_10_1177_0024363920926013 crossref_primary_10_1016_j_ymthe_2018_10_014 crossref_primary_10_1038_s41467_018_05059_x crossref_primary_10_1159_000539415 crossref_primary_10_3389_fgene_2024_1389558 crossref_primary_10_1186_s13287_019_1165_5 crossref_primary_10_1002_adtp_202000141 crossref_primary_10_1080_10409238_2019_1570075 crossref_primary_10_2174_1566523219666190902154511 crossref_primary_10_1186_s13287_018_1075_y crossref_primary_10_1016_j_gde_2023_102067 crossref_primary_10_1038_s12276_022_00880_3 crossref_primary_10_1089_cell_2023_0123 crossref_primary_10_1016_j_colsurfb_2021_111991 crossref_primary_10_1111_acel_13764 crossref_primary_10_1002_stem_2842 |
Cites_doi | 10.1016/j.cell.2006.07.024 10.1038/nature12586 10.1038/srep22490 10.1126/science.aaf4445 10.1371/journal.pone.0054754 10.1042/BST20140012 10.1016/j.cell.2014.01.005 10.1101/101188 10.1016/j.ymgme.2008.12.016 10.1016/j.stem.2016.11.020 10.1016/j.cell.2016.11.052 |
ContentType | Journal Article |
Copyright | The Authors. Published under the terms of the CC BY 4.0 license 2017 2017 The Authors. Published under the terms of the CC BY 4.0 license 2017 The Authors. Published under the terms of the CC BY 4.0 license. COPYRIGHT 2017 John Wiley & Sons, Inc. 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Authors. Published under the terms of the CC BY 4.0 license 2017 – notice: 2017 The Authors. Published under the terms of the CC BY 4.0 license – notice: 2017 The Authors. Published under the terms of the CC BY 4.0 license. – notice: COPYRIGHT 2017 John Wiley & Sons, Inc. – notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PIMPY PQEST PQQKQ PQUKI PRINS 5PM DOA |
DOI | 10.15252/emmm.201707650 |
DatabaseName | SpringerOpen Wiley Open Access Wiley Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Biological Science Database Access via ProQuest (Open Access) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: 24P name: Wiley-Blackwell Open Access Collection url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 4 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 5 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 6 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
DocumentTitleAlternate | Irene de Lázaro et al |
EISSN | 1757-4684 |
EndPage | 736 |
ExternalDocumentID | oai_doaj_org_article_f5e3e25ac7c64e4393cdfbfa8058e377 A765724954 10_15252_emmm_201707650 28455313 EMMM201707650 |
Genre | commentary Comment Journal Article Commentary |
GroupedDBID | --- 0R~ 1OC 24P 4.4 53G 5DZ 5GY 5VS 7X7 8-0 8-1 8AO 8FE 8FH 8FI 8FJ AAHHS AAZKR ABJNI ABOCM ABUWG ACCFJ ACGFO ACGFS ACPRK ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AEGXH AENEX AEQDE AFBPY AFKRA AHMBA AIAGR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BTFSW BVXVI C6C CCPQU D-9 DIK DU5 EBD EBS EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HK~ HMCUK HYE HZ~ IAO IHR ITC KQ8 LH4 LK8 LW6 M48 M7P M~E NNB O9- OIG OK1 OVD OVEED P2P PIMPY PQQKQ PROAC RHF RHI RNS ROL RPM SV3 TEORI UKHRP WIN XV2 31~ ACSMW AFZJQ EBLON GODZA H13 CGR CUY CVF ECM EIF NPM AAYXX CITATION AEUQT 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c6460-67b4f22ee89e5d8d6cec6847911f6eec202ceacc2c2b0800315f39ea72281dbd3 |
IEDL.DBID | RPM |
ISSN | 1757-4676 |
IngestDate | Mon Oct 21 19:39:29 EDT 2024 Tue Sep 17 21:15:27 EDT 2024 Thu Oct 10 20:47:08 EDT 2024 Fri Feb 23 00:21:20 EST 2024 Wed Nov 13 00:01:16 EST 2024 Thu Sep 26 15:40:55 EDT 2024 Sat Sep 28 08:30:23 EDT 2024 Sat Aug 24 00:52:23 EDT 2024 Sat Oct 19 01:30:56 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Attribution 2017 The Authors. Published under the terms of the CC BY 4.0 license. This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6460-67b4f22ee89e5d8d6cec6847911f6eec202ceacc2c2b0800315f39ea72281dbd3 |
ORCID | 0000-0001-5863-9593 0000-0002-2224-6672 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452046/ |
PMID | 28455313 |
PQID | 1904074241 |
PQPubID | 866378 |
PageCount | 4 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f5e3e25ac7c64e4393cdfbfa8058e377 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5452046 proquest_journals_1904074241 gale_infotracmisc_A765724954 gale_infotracacademiconefile_A765724954 crossref_primary_10_15252_emmm_201707650 pubmed_primary_28455313 wiley_primary_10_15252_emmm_201707650_EMMM201707650 springer_journals_10_15252_emmm_201707650 |
PublicationCentury | 2000 |
PublicationDate | June 2017 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: June 2017 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: Frankfurt – name: Hoboken |
PublicationTitle | EMBO molecular medicine |
PublicationTitleAbbrev | EMBO Mol Med |
PublicationTitleAlternate | EMBO Mol Med |
PublicationYear | 2017 |
Publisher | Nature Publishing Group UK John Wiley & Sons, Inc EMBO Press John Wiley and Sons Inc Springer Nature |
Publisher_xml | – name: Nature Publishing Group UK – name: John Wiley & Sons, Inc – name: EMBO Press – name: John Wiley and Sons Inc – name: Springer Nature |
References | Abad, Mosteiro, Pantoja, Canamero, Rayon, Ors, Grana, Megias, Dominguez, Martinez (CR1) 2013; 502 CR6 Takahashi, Yamanaka (CR9) 2006; 126 CR5 Wilson (CR10) 2009; 96 Ocampo, Reddy, Martinez‐Redondo, Platero‐Luengo, Hatanaka, Hishida, Li, Lam, Kurita, Beyret (CR7) 2016; 167 de Lazaro, Kostarelos (CR4) 2014; 42 Yilmazer, de Lazaro, Bussy, Kostarelos (CR11) 2013; 8 Ohnishi, Semi, Yamamoto, Shimizu, Tanaka, Mitsunaga, Okita, Osafune, Arioka, Maeda (CR8) 2014; 156 Chiche, Le Roux, von Joest, Sakai, Aguin, Cazin, Salam, Fiette, Alegria, Flamant (CR2) 2016; 20 Gao, Wang, Xiong, Chen (CR3) 2016; 6 2016; 20 2016; 354 2016; 167 2016; 6 2017 2009; 96 2006; 126 2013; 8 2014; 156 2013; 502 2014; 42 27984723 - Cell. 2016 Dec 15;167(7):1719-1733.e12 e_1_2_4_10_1 e_1_2_4_11_1 e_1_2_4_12_1 e_1_2_4_3_1 e_1_2_4_2_1 e_1_2_4_5_1 e_1_2_4_4_1 e_1_2_4_7_1 e_1_2_4_6_1 e_1_2_4_9_1 e_1_2_4_8_1 |
References_xml | – volume: 167 start-page: 1719 year: 2016 end-page: 1733 ident: CR7 article-title: amelioration of age‐associated hallmarks by partial reprogramming publication-title: Cell contributor: fullname: Beyret – volume: 8 start-page: e54754 year: 2013 ident: CR11 article-title: cell reprogramming towards pluripotency by virus‐free overexpression of defined factors publication-title: PLoS ONE contributor: fullname: Kostarelos – ident: CR6 – volume: 156 start-page: 663 year: 2014 end-page: 677 ident: CR8 article-title: Premature termination of reprogramming leads to cancer development through altered epigenetic regulation publication-title: Cell contributor: fullname: Maeda – volume: 502 start-page: 340 year: 2013 end-page: 345 ident: CR1 article-title: Reprogramming produces teratomas and iPS cells with totipotency features publication-title: Nature contributor: fullname: Martinez – ident: CR5 – volume: 20 start-page: 407 year: 2016 end-page: 414 ident: CR2 article-title: Injury‐induced senescence enables reprogramming in skeletal muscle publication-title: Cell Stem Cell contributor: fullname: Flamant – volume: 42 start-page: 711 year: 2014 end-page: 716 ident: CR4 article-title: cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration publication-title: Biochem Soc Trans contributor: fullname: Kostarelos – volume: 6 start-page: 22490 year: 2016 ident: CR3 article-title: reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury publication-title: Sci Rep contributor: fullname: Chen – volume: 96 start-page: 151 year: 2009 end-page: 157 ident: CR10 article-title: Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency publication-title: Mol Genet Metab contributor: fullname: Wilson – volume: 126 start-page: 663 year: 2006 end-page: 676 ident: CR9 article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors publication-title: Cell contributor: fullname: Yamanaka – volume: 502 start-page: 340 year: 2013 end-page: 345 article-title: Reprogramming produces teratomas and iPS cells with totipotency features publication-title: Nature – volume: 20 start-page: 407 year: 2016 end-page: 414 article-title: Injury‐induced senescence enables reprogramming in skeletal muscle publication-title: Cell Stem Cell – volume: 126 start-page: 663 year: 2006 end-page: 676 article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors publication-title: Cell – volume: 6 start-page: 22490 year: 2016 article-title: reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury publication-title: Sci Rep – volume: 167 start-page: 1719 year: 2016 end-page: 1733 article-title: amelioration of age‐associated hallmarks by partial reprogramming publication-title: Cell – year: 2017 article-title: Non‐viral induction of transient cell reprogramming in skeletal muscle to enhance tissue regeneration publication-title: bioRxiv – volume: 42 start-page: 711 year: 2014 end-page: 716 article-title: cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration publication-title: Biochem Soc Trans – volume: 96 start-page: 151 year: 2009 end-page: 157 article-title: Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency publication-title: Mol Genet Metab – volume: 8 start-page: e54754 year: 2013 article-title: cell reprogramming towards pluripotency by virus‐free overexpression of defined factors publication-title: PLoS ONE – volume: 354 year: 2016 article-title: Tissue damage and senescence provide critical signals for cellular reprogramming publication-title: Science – volume: 156 start-page: 663 year: 2014 end-page: 677 article-title: Premature termination of reprogramming leads to cancer development through altered epigenetic regulation publication-title: Cell – ident: e_1_2_4_10_1 doi: 10.1016/j.cell.2006.07.024 – ident: e_1_2_4_2_1 doi: 10.1038/nature12586 – ident: e_1_2_4_4_1 doi: 10.1038/srep22490 – ident: e_1_2_4_7_1 doi: 10.1126/science.aaf4445 – ident: e_1_2_4_12_1 doi: 10.1371/journal.pone.0054754 – ident: e_1_2_4_5_1 doi: 10.1042/BST20140012 – ident: e_1_2_4_9_1 doi: 10.1016/j.cell.2014.01.005 – ident: e_1_2_4_6_1 doi: 10.1101/101188 – ident: e_1_2_4_11_1 doi: 10.1016/j.ymgme.2008.12.016 – ident: e_1_2_4_3_1 doi: 10.1016/j.stem.2016.11.020 – ident: e_1_2_4_8_1 doi: 10.1016/j.cell.2016.11.052 |
SSID | ssj0065618 |
Score | 2.310632 |
Snippet | Reprogramming adult, fully differentiated cells to pluripotency
in vivo
via
Oct3/4
,
Sox2
,
Klf4
and
c‐Myc
(OSKM) overexpression has proved feasible in various... Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various... Reprogramming adult, fully differentiated cells to pluripotency via , , and (OSKM) overexpression has proved feasible in various independent studies and could... Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc ( OSKM ) overexpression has proved feasible in... Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various... Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c-Myc (OSKM) overexpression has proved feasible in various... Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed wiley springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 733 |
SubjectTerms | Adult c-Myc protein Cell Differentiation Cellular Reprogramming Commentaries Commentary EMBO34 EMBO39 Gene Expression Regulation Humans KLF4 protein Myc protein Oct-4 protein Octamer Transcription Factor-3 - genetics Pluripotency Regenerative medicine SOXB1 Transcription Factors - genetics Tissue engineering Transcription Factors Translation Tumorigenesis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hSiAuCMorUJAPSLSHqIlfyR4LalWBAgeo1JuVOBOxh81W7FLBv-G38MuYsZNoA0K9cNtNvBtnnp_teQC8wqzmum42xbJQqda80USwNKXRSNfJaCKf6FYf7PmFfndpLndafXFMWCwPHAl33BlUKE3tC281kvtUvu2ari4zU6IqYh55thgXU9EGE0gJO3vkG4uUTIEdivoYaeQxrlacgp4XtITndPsdfxTK9v9tnHe805-Rk9Px6RzcBu90dh_uDbBSnMTXeQC3sN-H27HR5I99uFMNR-gPYRO8E2dBii1_Gq2GiJ13xOHHT--rI4HfhwjZXiw3gjRdbEOA7UaMuZTx5zGUTqw7sex__bxeXq8FnwUILpYZIr9WNO9HcHF2-vnteTp0XkiJyJbzARrdSYlYLtC0ZWs9ekt-jCxjZxG9zKQni-2llw1DTpWbTi2wLqQk_Nu06jHs9esen4IwRllvCqkbo8gRqsbmXVbUtZdl2xjtEzgc6e-uYoENxwsTZpVjVrmJVQm8Yf5Mw7gydrhA8uIGeXE3yUsCr5m7jvWX6OTrIQ2BZsuVsNwJPanghtw6gYPZSNI7P789yocb9H7jCF5p3m3QeQJPoqhM0yUgQMTIVQLFTIhm7zO_0y-_hIrf3Ag-0zaBo1Hcdh75L2KpII83EdWdVlU1fXv2P0j8HO7yH8aAugPY2379hi8Ium2bl0FLfwNFXz4z priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库 dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtQw1IIiEBcEZQsU5AMS7SFq4jU9oYJaVaDAASrNzUqcF5jDZMrMtCp_z3uOEyYg4JbFUey3229j7BVkFdV1MykUVqZK0UETmqUpjgZ8jkITyKNbfjRn5-r9TM_igds6hlUOMjEI6mbp6Yz8EBWXon2cyt9cfE-paxR5V2MLjZvsVi4yQyFddjZuuNBUCed7qCFtigLBxNI-WmhxCIsFJaLnFjfylHS_pZVC8f4_RfSWjvo9fnJ0ok5N3KCjTu-ze9G45Mc9NTxgN6DbZbf7dpM_dtmdMjrSH7JV0FGUC8k3dDXIDt733-H7nz5_KA84XMc42Y7P1xz5nW9CmO2aDxmV_ed9QB1ftnze8av51ZKTQ4BTxcwQ_rXAaT9i56cnX96dpbH9QuqNMpQUUKtWCIDiCHRTNMaDN6jMUDy2BsCLTHgU2154UZPdKXPdyiOorBBoBNeNfMx2umUHTxnXWhqvrVC1lqgNZW3yNrNV5UXR1Fr5hO0P4HcXfZUNR7sTwpQjTLkRUwl7S-gZh1F57PBgufrqIre5VoMEoStvcSmANpf0TVu3VZHpAqS1CXtNyHXExAgmX8VcBJwtlcNyx_gnS125VcL2JiOR-fz09UAeLjL_2v0i1YQ96SllnC5aAwiMXCbMTmhosp7pm27-LZT9pm7wmTIJOxiobeuXfwOWDOT4P6C6k7Isx7tn_17Uc3aXhvbxcntsZ7O6hBdomW3ql4H9fgLAOzNk priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1JbtRAsISCQFwQhM0hoD4gkRwM416dA0IBJYpAhgOMlFvLbpdhJMZDZoYo-Q1v4WVUeSOGRNy8tOV27eXaAJ7hJOe-bjbG1KlYa_7RRGZpTKuRrpPQRI7oZh_s0VS_OzbHf8YBdQBcXera8Typ6fLbi7OT89fE8K-66T3yJc7nXFSeOHLK2X-_LjW56ZzHp4eQAtktSdr19rnkIW4KnGpDFKlGGqpp5P-vuL6gr_7OpRwCqmNzt9FXh3fgdmdoiv2WMu7CNaw34UY7evJ8E25mXVD9HqwafcV1kWLNR70cEe0sHrHz8dP7bFfgWZczW4vZShDvi3WTcrsSfXVl-3ibXCcWlZjVv36ezk4XgqMDgttnNrlgc9r3fZgeHnx-exR3sxjiYLXlCoFCV1IipntoyrS0AYMlzUaysrKIQU5kIBkeZJAFG6EqMZXaw9xJSRZxUaoHsFEvanwEgoBsg3FSF0aRalSFTaqJy_Mg07IwOkSw08Pff29bbnh2VRhrnrHmB6xF8IbxMyzjXtnNhcXyi-9Yz1cGFUqTB0efgmSAqVBWRZWnE5Oici6C54xdzzRGcAp5V5hAu-XeWH6f3uR4RLeOYHu0kjgxjG_39OF7QvZkcGn-_6CTCB62pDJst6e4CNyIiEbfM75Tz742PcB5NPxE2wh2e3K78MqrgKUaevwfUP1BlmXD2daVu34Mt3hVmze3DRvr5Q98QhbaunjacN5v95Y12w priority: 102 providerName: Scholars Portal – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3JbtQw9AkVgbggKFugIB-QaA8Ridf0WEatKlDgAJV6sxLnRcxhMogZKvgbvoUv4z1n0YRFiFsSO7HzdttvAXiOWcV53WyKhVOp1rzRRGZpSr2RnpPQRD7RLd_a8wv9-tJcDkmSOBZm9_zeSCNf4mrFAeO5owU3r82vkwIu2HdrYRejyCWbJG7kkSp0KXG-HXL4_OEDM_UTs_T_Lot3lNGvjpLTaenclo3K6OwO3B6sSHHSo_0uXMNuH270dSW_7cPNcjgxvwebqIw46FFs-WoUEqIvtCMO371_Ux4J_Do4xHZiuRHE2GIb_Wk3Ygyd7F_vPefEuhXL7sf3q-XVWvDWv-DcmNHRa0Xzvg8XZ6cfFufpUGghDVZbdv-vdSslYnGMpikaGzBYUlskCFuLGGQmAwnoIIOs2cJUuWnVMVZOSjJ360Y9gL1u3eEjEMYoG4yTujaK9J6qbd5mrqqCLJra6JDA4Qh__6nPp-F5HcKo8owqP6EqgVeMn6kbJ8KOD4g-_MBXvjWoUJoqOPoVJOtKhaat26rITIHKuQReMHY9syvBKVRD1AHNlhNf-RMayXH9bZ3AwawnsVmYN4_04Qc233iypjRvLug8gYc9qUzTJb1PwMhVAm5GRLP_mbd0y48xwTfXfc-0TeBoJLedIf8GLBXp8V9A9adlWU53j_9jhCdwi697N7kD2Nt-_oJPySDb1s8iM_4E8qctUg priority: 102 providerName: Springer Nature – databaseName: Wiley Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB6kovgiWm_RKvsg2D4Ek72mj1VaihIVtODbkmwmeh5OjjTHov_G3-Ivc2ZzoVFE8C2XTbKZndvuznwD8BSzinHdbIqFU6nWvNBEbmlKrZGuk9JE3tEt39jTM_3qo5miCTkXZsCHmBfcWDKivmYBr-p-qtjDqKG4XnMqee5oKs6z9quMG8Pw-VK_m5QxeStxiY-MpEtJJ9gR3Ydf8Xz5goVhivj9f2rpS2bq9xDKeR916eVGM3VyC26O_qU4GhjiNlzBbheuDRUnv-_C9XLcS78DfTRTnA4ptnw0qQ8xlOAR-2_fvy4PBH4bQ2U7seoFibzYxkjbXkxJlcPjQ0yd2LRi1f38cbG62AjeFBCMmhlDwNbU77twdnL84eVpOpZgSIPVlhMDat1KiVgcommKxgYMlgwaqcjWIgaZyUCqO8gga_Y9VW5adYiVk5Ic4bpR92Cn23T4AIQxygbjpK6NIouoapu3mauqIIumNjoksD_R338ZkDY8z1B4qDwPlZ-HKoEXPD5zM4bIjhc255_8KHG-NahQmio4-hUkv0uFpq3bqshMgcq5BJ7x6HoWZKJTqMZ8BOotQ2L5I_qS48rcOoG9RUsSwLC8PfGHHxVA78nP0rzsoPME7g-sMneXPAIiRq4ScAsmWvzP8k63-hyhv7kifKZtAgcTu1365N-IpSI__ouo_rgsy_ns4X899Qhu8PEQSrcHO9vzr_iYnLZt_SSK5S_LDTjZ priority: 102 providerName: Wiley-Blackwell |
Title | Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming |
URI | https://link.springer.com/article/10.15252/emmm.201707650 https://onlinelibrary.wiley.com/doi/abs/10.15252%2Femmm.201707650 https://www.ncbi.nlm.nih.gov/pubmed/28455313 https://www.proquest.com/docview/1904074241 https://pubmed.ncbi.nlm.nih.gov/PMC5452046 https://doaj.org/article/f5e3e25ac7c64e4393cdfbfa8058e377 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bbtMw9GgdAu0FwbgFRuUHJLaHrK2v2eNWdZpAGRUwqW9W4jojEk2ntZvgb_gWvoxznKRaQAiJlygXJ7HP3fa5ALzxw4zyuunYJ0bEUtJCE5qlMbb2eB-Fpqcd3fRcn13IdzM12wLVxsIEp32Xl4fV18VhVX4JvpVXCzdo_cQG03RMdbFpa7IHPSTQdopei1-0T8KiHqpFE6MU0E0-H8UVH_jFgqLPRwZn74qKwKFwVkiFoqOVQvL-P0X0HR31u__kZhO1a-IGHXX6CB42xiU7rgfxGLZ8tQv363KT33fhQdpspD-BVdBRFAvJ1nTWyg5W199h-x8-vU8PmP_W-MlWrFwx5He2Dm62K9ZGVNav1w51bFmwsvr547a8XTLaEWCUMjP4fy2w30_h4nTyeXwWN_UXYqelpqiAXBace58ceTVP5tp5p1GboXwstPeOD7lDue244zkZnmKkCnHkM8M5WsH5XDyD7WpZ-RfAEMjaKcNlrgSqQ5HrUTE0WeZ4Ms-VdBHst_C3V3WaDUvTE8KaJazZDdYiOCH8bJpRfuxwY3l9aRsqsYXywnOVOYND8Wh0CTcv8iJLhirxwpgI3hJ2LXExwsllTTAC9pbyYdlj_JOhstwygr1OS-Q-133c0odtuH9l0ciStOYgRxE8r0ll092W4iIwHSLqjKf7BNkg5P1uyD6Cg5bc7vzyb8ASgR7_BVQ7SdN0c_Xyv_v2CnboK7Uv3R5sr69v_Gu02tZ5H3pcTvFoZqYP904m59OPeDXW435YB8FjKpN-4OVftSBDpw |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,11574,12068,21400,24330,27936,27937,31731,33756,41132,42201,43322,43817,46064,46488,50826,50935,51588,53804,53806,74073,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtQw9AmKWC4IyhYo4AMS7SHqjNf0hApqNdCmHGiluVmJ48AcJlNmhgr-nvccJ0xAwC2Lo9hvt98G8MqPCqrrplOfGZFKSQdNaJamONrjcxSanjy6-ZmeXMgPUzWNB26rGFbZycQgqKuFozPyfVRckvZxcvzm8mtKXaPIuxpbaFyHG1SHizoYmGm_4UJTJZzvoYY0KQoEHUv7KK74vp_PKRF9bHAjT0n3G1opFO__U0Rv6Kjf4yd7J-rQxA066vge3I3GJTtsqeE-XPPNNtxs203-2IZbeXSkP4Bl0FGUC8nWdNXJDtb232G7Hz-d5HvMf49xsg2brRjyO1uHMNsV6zIq28_bgDq2qNmsYVezqwUjhwCjipkh_GuO034IF8dH5-8maWy_kDotNSUFlLLm3PvswKsqq7TzTqMyQ_FYa-8dH3GHYttxx0uyO8VY1eLAF4ZzNILLSjyCrWbR-CfAlBLaKcNlqQRqQ1HqcT0yReF4VpVKugR2O_Dby7bKhqXdCWHKEqZsj6kE3hJ6-mFUHjs8WCw_28httlZeeK4KZ3ApHm0u4aq6rItspDIvjEngNSHXEhMjmFwRcxFwtlQOyx7inwx15ZYJ7AxGIvO54euOPGxk_pX9RaoJPG4ppZ8uWgMIjLFIwAxoaLCe4Ztm9iWU_aZu8COpE9jrqG3jl38Dlgjk-D-g2qM8z_u7p_9e1Eu4PTnPT-3p-7OTZ3CHPmtj53Zga7385p-jlbYuXwRW_AlAQTZL |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtNA9AlSUXFBUDZDgTkg0R6sOrO6J9RCokJxqIBKvY3s8RhyiFOSUMHf8549DjEIuHkZyzNvn3kbwHOf5FTXTcc-NSKWkg6a0CyNcbTH5yg0PXl0s4k-OZdvL9RFiH9ahrDKTiY2grqcOzojP0DFJWkfJ4cHVQiLOHs9fnn5NaYOUuRpDe00rsOWkVokA9g6Hk3OPnRyGQ2X5rQP9aWJUTzoUOhHccUP_GxGaelDg9t6SsHf0FFNKf8_BfaGxvo9mnLtUu0bvI3GGt-GW8HUZEctbdyBa77egRtt88kfO7CdBbf6XVg0GosyI9mKrjpJwtpuPGzv_cfTbJ_57yFqtmbTJUPuZ6sm6HbJuvzK9vM2vI7NKzat2dX0as7IPcCofmYTDDbDad-D8_Ho06uTODRjiJ2WmlIECllx7n166FWZltp5p1G1obCstPeOJ9yhEHfc8YKsUDFUlTj0ueEcTeKiFPdhUM9r_xCYUkI7ZbgslEDdKAo9rBKT546nZaGki2CvA7-9bGtuWNqrEKYsYcquMRXBMaFnPYyKZTcP5ovPNvCerZQXnqvcGVyKRwtMuLIqqjxNVOqFMRG8IORaYmkEk8tDZgLOlopj2SP8k6Ee3TKC3d5IZEXXf92Rhw2iYGl_EW4ED1pKWU8XbQMExlBEYHo01FtP_009_dIUAafe8InUEex31Lbxy78BSzTk-D-g2lGWZeu7R_9e1DPYRj60795MTh_DTfqqDaTbhcFq8c0_QZNtVTwNvPgTb5476A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transient+transcription+factor+%28OSKM%29+expression+is+key+towards+clinical+translation+of+in%C2%A0vivo+cell+reprogramming&rft.jtitle=EMBO+molecular+medicine&rft.au=de+L%C3%A1zaro%2C+Irene&rft.au=Cossu%2C+Giulio&rft.au=Kostarelos%2C+Kostas&rft.date=2017-06-01&rft.eissn=1757-4684&rft.volume=9&rft.issue=6&rft.spage=733&rft_id=info:doi/10.15252%2Femmm.201707650&rft_id=info%3Apmid%2F28455313&rft.externalDocID=28455313 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-4676&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-4676&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-4676&client=summon |